Literature DB >> 18627343

Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.

Mekdes Debela1, Nathalie Beaufort, Viktor Magdolen, Norman M Schechter, Charles S Craik, Manfred Schmitt, Wolfram Bode, Peter Goettig.   

Abstract

Human kallikrein-related peptidases (KLKs) are (chymo)-trypsin-like serine proteinases that are expressed in a variety of tissues such as prostate, ovary, breast, testis, brain, and skin. Although their physiological functions have been only partly elucidated, many of the KLKs appear to be useful prognostic cancer markers, showing distinct correlations between their expression levels and different stages of cancer. Recent advances in the purification of 'new type' recombinant KLKs allowed solution of the crystal structures of KLK4, KLK5, KLK6, and KLK7. Along with these data, enzyme kinetic studies and extended substrate specificity profiling have led to an understanding of the non-prime-side substrate preferences of KLK4, 5, 6, and 7. The shape and polarity of the specificity pockets S1-S4 explain well their substrate preferences. KLK4, 5, and 6 exhibit trypsin-like specificity, with a strong preference for Arg at the P1 position of substrates. In contrast, KLK7 displays a unique chymotrypsin-like specificity for Tyr, which is also preferred at P2. All four KLKs show little specificity for P3 residues and have a tendency to accept hydrophobic residues at P4. Interestingly, for KLK4, 5, and 7 extended charged surface regions were observed that most likely serve as exosites for physiological substrates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627343     DOI: 10.1515/BC.2008.075

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  27 in total

Review 1.  Kallikreins - The melting pot of activity and function.

Authors:  Magdalena Kalinska; Ulf Meyer-Hoffert; Tomasz Kantyka; Jan Potempa
Journal:  Biochimie       Date:  2015-09-25       Impact factor: 4.079

2.  Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs.

Authors:  Mélia Magnen; Fabien Gueugnon; Antoine Guillon; Thomas Baranek; Virginie C Thibault; Agnès Petit-Courty; Simon J de Veer; Jonathan Harris; Alison A Humbles; Mustapha Si-Tahar; Yves Courty
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 3.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

Review 4.  Meprin A metalloproteinase and its role in acute kidney injury.

Authors:  Gur P Kaushal; Randy S Haun; Christian Herzog; Sudhir V Shah
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-20

5.  Characterization of kallikrein-related peptidase 4 glycosylations.

Authors:  Yasuo Yamakoshi; Fumiko Yamakoshi; Jan C-C Hu; James P Simmer
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

6.  MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis.

Authors:  Alison J Kriegel; Yong Liu; Brett Cohen; Kristie Usa; Youhua Liu; Mingyu Liang
Journal:  Physiol Genomics       Date:  2011-12-27       Impact factor: 3.107

7.  Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.

Authors:  Audrey Guillon-Munos; Katerina Oikonomopoulou; Noémie Michel; Chistopher R Smith; Agnès Petit-Courty; Sylvie Canepa; Pascale Reverdiau; Nathalie Heuzé-Vourc'h; Eleftherios P Diamandis; Yves Courty
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

8.  Basic Residues of β-Sheet A Contribute to Heparin Binding and Activation of Vaspin (Serpin A12).

Authors:  David Ulbricht; Kathrin Oertwig; Kristin Arnsburg; Anja Saalbach; Jan Pippel; Norbert Sträter; John T Heiker
Journal:  J Biol Chem       Date:  2016-12-09       Impact factor: 5.157

9.  Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.

Authors:  Valérie Gratio; Nathalie Beaufort; Lina Seiz; Josefine Maier; G Duke Virca; Mekdes Debela; Nicolai Grebenchtchikov; Viktor Magdolen; Dalila Darmoul
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

10.  In vitro amyloidogenic peptides of galectin-7: possible mechanism of amyloidogenesis of primary localized cutaneous amyloidosis.

Authors:  Koji Ono; Eita Fujimoto; Norihiro Fujimoto; Minoru Akiyama; Takahiro Satoh; Hiroki Maeda; Noriko Fujii; Shingo Tajima
Journal:  J Biol Chem       Date:  2014-08-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.